Mar 24, 2025
The Prescription Drug Data Collection (RxDC) reporting provision of the Consolidated Appropriations Act (CAA) requires reports on drug utilization and spending trends be submitted to the U.S. Department of Health and Human Services each year. The next RxDC report is due by June 1, 2025. Anthem will follow the same process as in prior years.
The deadline for employers to complete the RFI survey has been extended to March 28, 2025,
FAQs
Q. D2 Filing – Will Anthem be filing the D2 (Spending by Category) file for fully insured clients?
A. Yes
Q. Employer Surveys – Will Anthem be surveying/sending an Request for Information (RFI) to group clients to verify employer contributions for the D1 (Premium and Life Years) filing?
A. Yes
Q. What is the deadline for group clients to respond to the RFI?
A. Extended to March 28, 2025.
Q. What happens if an employer misses the March 28, 2025 deadline to respond to the RFI?
A. Anthem will file without the group's reported information
Q. What type of communication will anthem send to employers regarding the RFI?
A. Surveys will be sent to employers the week of 2/17/2025
Q. Employer Confirmation – How can employers confirm their CAA RxDC files have been filed?
A. Emails will be sent to employers and a news article will be posted for broker once the filing has happened.
Q. File Access – Can employers access copies of their P2 and D1-D8 files once they have been filed?
A. Every month the reports are posted to a site that employers can access. Machine Readable Files
Click here to read more details from Anthem.
For more information about the Consolidated Appropriations Act RxDC reporting requirements, please visit our CAA/Transparency Resource Center, CMS’ RxDC information page, or contact your Amwins team. We are here to help.
